The iMBA team is available to assist you at all times. We recommend that you bookmark this page for future reference, as it will be very useful as you complete the program. If you have any questions or issues, please contact us at i-support@illinois.edu.
iConverge is our annual on-campus networking and professional development event. It is a chance for students to see familiar friends, make new ones and develop professional relationships outside the classroom.
Gies College of Business grants degrees three times a year -- in May, August, and December. You need to submit an application for graduation in your final term in order to place your name on the degree list and receive your diploma.
PODCAST: The Surprising Link Between FDA Action and Drug Supply
Apr 7, 2026, 09:05
by
Mike Koon
In this episode of Research Reverb, Gies Business professors Gopesh Anand and Iris Wang discuss their research, which shows that unfavorable FDA inspection outcomes are linked to fewer future drug shortages.
Since its inception, the Food and Drug Administration has regulated drug quality. In 2012, Congress passed the Food and Drug Administration Safety and Innovation Act, and as part of the FDA, it also took on the role of trying to understand and prevent supply chain and drug shortages.
You might think that, as drug shortages became a concern, there was fear that plant managers' shift in attention toward quality concerns would cause supply to dip further, leading to even greater future shortages. Gies researchers Iris Wang and Gopesh Anand found just the opposite. In this episode of Research Reverb, they share how they refuted a 2019 study that had indicated that, as the FDA posed an Official Action Indicated, where improvements were required, the drug supply slowed.
